Liora M. Schultz

Organoid Modeling of the Tumor Immune Microenvironment

James T. Neal, Xingnan Li, Junjie Zhu et al. · Cell · 2018 · 1.5K citations · Full text

Life Sciences, Cancer Biology, Immunology +14

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas

Robbie G. Majzner, Sneha Ramakrishna, Kristen W. Yeom et al. · Nature · 2022 · 782 citations · Full text

Medicine, Immunology, Oncology +13

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Jay Y. Spiegel, Shabnum Patel, Lori Muffly et al. · Nature Medicine · 2021 · 572 citations · Full text

Medicine, Hematology, Oncology +17

Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas

Michelle Monje, Jasia Mahdi, Robbie G. Majzner et al. · Nature · 2024 · 173 citations · Full text

Medicine, Oncology, Pharmacology +15

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

Vanessa A. Fabrizio, Jaap Jan Boelens, Audrey Mauguen et al. · Blood Advances · 2021 · 111 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16